Skip to content
Bomb Report – Lifestyle
Author:
Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting
September 8, 2026
Code of Cultures Probiotic Brand owned by Fischer Sciences Inc. Launches New Campaign to Help Consumers Rethink Gut Health and Daily Wellness
May 7, 2026
Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome
March 31, 2026